Benefits of lifestyle modification in NAFLD

被引:184
作者
Harrison, Stephen A.
Day, Christopher Paul
机构
[1] Newcastle Univ, Sch Med, Inst Cellular Med, Liver Res Grp,Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Brooke Army Med Ctr, Div Gastroenterol & Hepatol, Houston, TX USA
关键词
D O I
10.1136/gut.2006.112094
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Excessive foodstuffs, particularly in the form of complex carbohydrates, increased fructose consumption and saturated fats, combined with a sedentary lifestyle have contributed to the epidemic of obesity, dysregulated metabolism and NAFLD. Our knowledge of the pathological consequences of poor dietary choices and lack of adequate exercise on adipose tissue, skeletal muscle and the liver is improving, and this will help in establishing more specific guidelines for the proper nutrient intake and exercise regimens that will improve underlying metabolic pathways and ultimately decrease the incidence and severity of NAFLD. For now it seems that diets aimed at reducing total daily energy intake, based on either a low processed carbohydrate, or low-fat macronutrient platform, aimed at achieving about a 10% weight reduction, will improve both metabolic and histopathological abnormalities in a diverse group of NAFLD patients. Moderate exercise, preferably a combination of aerobic and restrictive, performed 3-4 times per week, expending about 400 calories each time seems adequate to augment improvement in the metabolic profiles of patients with NAFLD. More rigorous, controlled studies, of longer duration and defined histopathological end-points comparing diet alone, exercise alone and diet plus exercise are needed before better, evidence-based lifestyle modification guidelines can be established, since several questions remain unanswered. Does lifestyle modification work equally well in men versus women? Do younger patients respond better than older patients to lifestyle modification? Is there a diversity of response among various ethnic groups or in patients with fatty liver alone compared with patients with more progressive disease? Do diabetic patients with NAFLD have a better histopathological response to lifestyle modification than insulin-resistant patients without diabetes and, if so, does the same amount of weight loss equate to histopathological improvement, or do these patients need to lose more or less weight, or simply need to exercise more? Finally, are there different lifestyle modification approaches, i.e. diet alone versus diet and aerobic exercise, that work better for different patient populations?
引用
收藏
页码:1760 / 1769
页数:10
相关论文
共 88 条
[1]   HEPATIC-EFFECTS OF DIETARY WEIGHT-LOSS IN MORBIDLY OBESE SUBJECTS [J].
ANDERSEN, T ;
GLUUD, C ;
FRANZMANN, MB ;
CHRISTOFFERSEN, P .
JOURNAL OF HEPATOLOGY, 1991, 12 (02) :224-229
[2]   Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis [J].
Baba, CS ;
Alexander, G ;
Kalyani, B ;
Pandey, R ;
Rastogi, S ;
Pandey, A ;
Choudhuri, G .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) :191-198
[3]   Non-alcoholic steatohepatitis: Effect of Roux-en-Y gastric bypass surgery [J].
Barker, KB ;
Palekar, NA ;
Bowers, SP ;
Goldberg, JE ;
Pulcini, JP ;
Harrison, SA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) :368-373
[4]   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[5]   Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: Associations with metabolic parameters and insulin resistance and regulation by physical training [J].
Bluher, Matthias ;
Bullen, John W., Jr. ;
Lee, Jennifer H. ;
Kralisch, Susan ;
Fasshauer, Mathias ;
Kloting, Nora ;
Niebauer, Josef ;
Schon, Michael R. ;
Williams, Catherine J. ;
Mantzoros, Christos S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) :2310-2316
[6]   Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[7]  
Capristo E, 2005, Eur Rev Med Pharmacol Sci, V9, P265
[8]   Apolipoprotein synthesis in nonalcoholic steatohepatitis [J].
Charlton, N ;
Sreekumar, R ;
Rasmussen, D ;
Lindor, K ;
Nair, KS .
HEPATOLOGY, 2002, 35 (04) :898-904
[9]   Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? [J].
Chitturi, S ;
Farrell, G ;
Frost, L ;
Kriketos, A ;
Lin, R ;
Liddle, C ;
Samarasinghe, D ;
George, J .
HEPATOLOGY, 2002, 36 (02) :403-409
[10]   Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease [J].
Church, Timothy S. ;
Kuk, Jennifer L. ;
Ross, Robert ;
Priest, Elisa L. ;
Biltoff, Emily ;
Blair, Steven N. .
GASTROENTEROLOGY, 2006, 130 (07) :2023-2030